Family of man who died after taking weight-loss drug Mounjaro want probe into its ‘potential to kill’

THE family of a man who died after taking Mounjaro want a probe into the weight-loss drug’s “potential to kill”.

It comes after The Sun revealed 82 deaths have been linked to anti-fat and diabetes jabs.

Slimmers taking Mounjaro for weight loss account for 10 of the total up to the end of January, with others linked to injections including Ozempic, Wegovy and Saxenda.

Ade Robinson, 60, of Burton upon Trent, Staffs, lost 2st after injecting Mounjaro before dying in hospital last November.

The preliminary cause was said to be pancreatitis — a possible side effect of the drug, which is to be rolled out on the NHS — and sepsis.

A source close to Ade’s family said: “He was absolutely fine before he started taking it.

“This drug should not be being dished out like sweets.

“Pancreatitis is a known side effect of the drug, so the link shouldn’t be ignored.

“If it’s going to be rolled out on the NHS, it needs to be properly investigated.

“Millions of people could be handed it for free and so, if the results can be fatal, this needs addressing.”

Mounjaro manufacturer Lilly UK said: “We sympathise with Mr Robinson’s family for their loss.

“Patient safety is Lilly’s top priority.

“Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data.

“If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.”

Jabs like Mounjaro, known as GLP-1 receptor agonists, were originally used to treat type 2 diabetes but can now be prescribed for weight loss.